What does the evidence say about Cinnamon Glycemic Control Meta-Analysis?

The current Migaku evidence database contains 2 reusable source documents for Cinnamon Glycemic Control Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation. - Conclusion Cinnamon can be used as an anti-diabetic agent and an add-on treatment to control glycemic indices among patients with T2D or PCOS. [Zarezadeh M (2023); evidence level 1] - Background Several meta-analyses reported glycemic-lowering effects of cinnamon, while others reported conflicting findings. [Zarezadeh M (2023); evidence level 1] - In the present study, we aimed to perform an umbrella meta-analysis of previous interventional meta-analyses on the effects of cinnamon on glycemic control in patients with type 2 diabetes (T2D) or with polycystic ovary syndrome (PCOS). [Zarezadeh M (2023); evidence level 1] - The use of complementary and alternative medicine (CAM) is increasingly popular for the management of diabetes mellitus (DM). [Setiyorini E (2022); evidence level 1] - The aim of this study was to conduct systematic review of any types of complementary and alternative medicine for glycemic control of diabetes mellitus. [Setiyorini E (2022); evidence level 1] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.